Back to search
Advanced and/or Metastatic Sarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced and/or Metastatic Sarcoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced and/or Metastatic Sarcoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of…
A first in human study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of BLU-924 / SAR449336, a pan-KRAS inhibitor, in participa…
This is a phase 1, non-randomized open-label, multicenter platform study designed to evaluate the tolerability and safety of AB122 in patients with malignancies…
The purpose of this research study is to see how metformin, when used in combination with standard of care (SOC) treatment for metastatic (cancer that has sprea…
The main goal of this study is to test a new medicine, Risvutatug Rezetecan also called Ris-Rez. We want to see if this medicine can help people with certain ty…
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.
This trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors. This trial is a sub study of the Master…
This trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors.